Tuan Nguyen

CIK: 0002063445

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (28.6%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)2 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ABUS

Arbutus Biopharma Corp

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

ABUS
Arbutus Biopharma Corp
Oct 1, 2026
Disposition(D)
Direct
48.1K shares at avg. $5.00$240K
ABUS
Arbutus Biopharma Corp
Sep 18, 2026
Exercise(M)
Direct
265.6K shares at avg. $3.49$927K
ABUS
Arbutus Biopharma Corp
Sep 18, 2026
Exercise(M)
Direct
27.5K shares at avg. $4.39$121K
ABUS
Arbutus Biopharma Corp
Sep 18, 2026
Tax Payment(F)
Direct
206.6K shares at avg. $5.07$1.0M
ABUS
Arbutus Biopharma Corp
Feb 2, 2026
Award(A)
Direct
73.5K shares-
ABUS
Arbutus Biopharma Corp
Mar 31, 2025
Award(A)
Stock Option (Right to Buy)
Direct
750K shares-
ABUS
Arbutus Biopharma Corp
Mar 31, 2025
Award(A)
Stock Option (Right to Buy)
Direct
750K shares-

		Type	Shares	Price		Ownership
Oct 1, 2026	ABUS Arbutus Biopharma Corp	Disposition(D)	48,081	$5.00	$240,405	Direct
Sep 18, 2026	ABUS Arbutus Biopharma Corp	Exercise(M)	265,625	$3.49	$927,031	Direct
Sep 18, 2026	ABUS Arbutus Biopharma Corp	Exercise(M)	27,475	$4.39	$120,615	Direct
Sep 18, 2026	ABUS Arbutus Biopharma Corp	Tax Payment(F)	206,637	$5.07	$1,047,650	Direct
Feb 2, 2026	ABUS Arbutus Biopharma Corp	Award(A)	73,500	-	$0	Direct
Mar 31, 2025	ABUS Arbutus Biopharma Corp	Award(A) Stock Option (Right to Buy)	750,000	-	-	Direct
Mar 31, 2025	ABUS Arbutus Biopharma Corp	Award(A) Stock Option (Right to Buy)	750,000	-	-	Direct

1-7 of 7 transactions

About Nguyen Tuan

Nguyen Tuan (SEC CIK 0002063445) files insider reports with the SEC as Chief Financial Officer of Arbutus Biopharma Corp (ABUS).

Signal8 holds 6 ownership filings by Nguyen Tuan (1 Form 3, 5 Form 4), filed between Mar 31, 2025 and Oct 7, 2026. Those filings report 7 transactions, from Mar 31, 2025 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Nguyen Tuan's filings is in WARMINSTER, PA.

Recent filings by Nguyen Tuan

Oct 1, 2026: Disposition to issuer transaction of ABUS shares (Form 4, code D).
Sep 18, 2026: Option exercises of ABUS shares (2 lines, Form 4, code M).
Sep 18, 2026: Tax withholding of ABUS shares (Form 4, code F).
Feb 2, 2026: Grant or award of ABUS shares (Form 4, code A).
Mar 31, 2025: Grants or awards of ABUS derivative securities (2 lines, Form 4, code A).

Other insiders filing for Arbutus Biopharma Corp (ABUS)

Beardsley Robert A, Director
Sawhney Roger, Director
Androski Lindsay, President and CEO
Hasija Anuj, Director
Bishop Joseph E, Director
Gline Matthew, Director

How to read Form 4 transaction codes